Table 3 Comparison between groups A versus B
|
Group A No = 29 |
Group B No = 32 | P value | |
|---|---|---|---|
| Age | 60 (21–82) | 59 (33–79) | 0.426 |
| Sex | |||
| • Male | 13 (44.8%) | 16 (50.0%) | 0.686 |
| • Female | 16 (55.2%) | 16 (50.0%) | |
| Clinical presentation | |||
| • Jaundice | 26 (89.7%) | 17 (53.1%) | 0.002 |
| • Abdominal pain | 2 (6.9%) | 8 (25.0%) | 0.056 |
| • Incidental biliary dilatation | 2 (3.4%) | 7 (21.9%) | 0.033 |
| Laboratory data | |||
| • Total bilirubin | 5.3 (0.4–37.0) | 1.4 (0.5–39.0) | 0.002 |
| • ALT | 54.0 (21.0–201.0) | 45.5(11.0–239.0) | 0.466 |
| • AST | 50.0 (23.0–288.0) | 44.0(19.0–210.0) | 0.355 |
| • Alkaline phosphatase | 250 (160–1260) | 190 (47–647) | 0.022 |
| CBD diameter by EUS | 13.7 ± 2.92 | 11.55 ± 3.14 | 0.006 |